Exploratory Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic Cell Injection (YS247, Beijing YSCell Biotech Co., Ltd. [Abbreviated as YS])in Patients With Recurrent or Progressive Glioblastoma
Clinical trial NCT07678138 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07678138
- Sponsor
- Huanhu Hospital Affiliated to Tianjin Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2027-11-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.